|
Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial
|
15 September 2013 |
|
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial
|
13 September 2013 |
|
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors
|
13 September 2013 |
|
Retinoic acid induces caspase-8 transcription via phospho-CREB and increases apoptotic responses to death stimuli in neuroblastoma cells
|
13 September 2013 |
|
Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery
|
12 September 2013 |
|
Detection of somatostatin receptors in human osteosarcoma
|
12 September 2013 |
|
Anti-angiogenic activity of tocotrienol
|
12 September 2013 |
|
Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells
|
12 September 2013 |
|
The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells
|
10 September 2013 |
|
Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways
|
10 September 2013 |